Our study further elucidates a functional mechanism where EFNA1 cis-interacts with its receptor EphA2, leading to EphA2 degradation and subsequent activation of the Src/AKT/STAT3 pathway, thereby promoting tumor progression in CC. Here, EPHA2 is linked to neoplasm.